Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
Peritonitis remains a primary challenge for the long-term success of peritoneal dialysis (PD) technique and one of the main reasons for catheter removal. Prevention and treatment of catheter-related infections are major concerns to avoid peritonitis. The use of taurolidine catheter-locking solution...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Kidney Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590059520301357 |
id |
doaj-c19e2853e891473a8f4452bf404f97f4 |
---|---|
record_format |
Article |
spelling |
doaj-c19e2853e891473a8f4452bf404f97f42020-11-25T03:38:19ZengElsevierKidney Medicine2590-05952020-09-0125650651Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis PeritonitisMarta Alvarez Nadal0R. Haridian Sosa Barrios1Víctor Burguera Vion2Cristina Campillo Trapero3Milagros Fernández Lucas4Maite E. Rivera Gorrín5Servicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, Spain; Address for Correspondence: R. Haridian Sosa Barrios, MD, MSc, Ctra Colmenar Viejo km 9.1, 28034 Madrid, Spain.Servicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, Spain; Universidad de Alcalá, UAH, Madrid, Spain; Instituto Ramón y Cajal de Investigaciones Sanitarias (IryCis), Madrid, Spain; Red de Investigación Renal (RedinREn), Madrid, SpainServicio de Nefrología. Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Nefrología Diagnóstica e Intervencionista _(GNDI) de la Sociedad Española de Nefrología, Madrid, Spain; Universidad de Alcalá, UAH, Madrid, Spain; Instituto Ramón y Cajal de Investigaciones Sanitarias (IryCis), Madrid, Spain; Red de Investigación Renal (RedinREn), Madrid, SpainPeritonitis remains a primary challenge for the long-term success of peritoneal dialysis (PD) technique and one of the main reasons for catheter removal. Prevention and treatment of catheter-related infections are major concerns to avoid peritonitis. The use of taurolidine catheter-locking solution to avoid the development of a biofilm in the catheter’s lumen has obtained good results in hemodialysis catheters for reducing infection rates, although there is scarce literature available regarding its utility in PD. We describe the case of a woman in her 60s who developed relapsing peritonitis due to Pseudomonas aeruginosa, with no possibility of removing peritoneal dialysis catheter because she was not a suitable candidate for hemodialysis. After the fourth peritonitis episode caused by Pseudomonas species, the use of taurolidine catheter-locking solution was initiated. She received a total of 9 doses, with a favorable microbiological and clinical outcome and no further relapses more than 10 months after taurolidine PD catheter lock treatment was started. We report the successful elimination of an aggressive bacteria after taurolidine PD catheter lock use, with no relevant adverse events.http://www.sciencedirect.com/science/article/pii/S2590059520301357TaurolidinePseudomonas peritonitisperitoneal dialysisbiofilmcatheter lock |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Marta Alvarez Nadal R. Haridian Sosa Barrios Víctor Burguera Vion Cristina Campillo Trapero Milagros Fernández Lucas Maite E. Rivera Gorrín |
spellingShingle |
Marta Alvarez Nadal R. Haridian Sosa Barrios Víctor Burguera Vion Cristina Campillo Trapero Milagros Fernández Lucas Maite E. Rivera Gorrín Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis Kidney Medicine Taurolidine Pseudomonas peritonitis peritoneal dialysis biofilm catheter lock |
author_facet |
Marta Alvarez Nadal R. Haridian Sosa Barrios Víctor Burguera Vion Cristina Campillo Trapero Milagros Fernández Lucas Maite E. Rivera Gorrín |
author_sort |
Marta Alvarez Nadal |
title |
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis |
title_short |
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis |
title_full |
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis |
title_fullStr |
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis |
title_full_unstemmed |
Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis |
title_sort |
taurolidine peritoneal dialysis catheter lock to treat relapsing peritoneal dialysis peritonitis |
publisher |
Elsevier |
series |
Kidney Medicine |
issn |
2590-0595 |
publishDate |
2020-09-01 |
description |
Peritonitis remains a primary challenge for the long-term success of peritoneal dialysis (PD) technique and one of the main reasons for catheter removal. Prevention and treatment of catheter-related infections are major concerns to avoid peritonitis. The use of taurolidine catheter-locking solution to avoid the development of a biofilm in the catheter’s lumen has obtained good results in hemodialysis catheters for reducing infection rates, although there is scarce literature available regarding its utility in PD. We describe the case of a woman in her 60s who developed relapsing peritonitis due to Pseudomonas aeruginosa, with no possibility of removing peritoneal dialysis catheter because she was not a suitable candidate for hemodialysis. After the fourth peritonitis episode caused by Pseudomonas species, the use of taurolidine catheter-locking solution was initiated. She received a total of 9 doses, with a favorable microbiological and clinical outcome and no further relapses more than 10 months after taurolidine PD catheter lock treatment was started. We report the successful elimination of an aggressive bacteria after taurolidine PD catheter lock use, with no relevant adverse events. |
topic |
Taurolidine Pseudomonas peritonitis peritoneal dialysis biofilm catheter lock |
url |
http://www.sciencedirect.com/science/article/pii/S2590059520301357 |
work_keys_str_mv |
AT martaalvareznadal taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis AT rharidiansosabarrios taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis AT victorburgueravion taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis AT cristinacampillotrapero taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis AT milagrosfernandezlucas taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis AT maiteeriveragorrin taurolidineperitonealdialysiscatheterlocktotreatrelapsingperitonealdialysisperitonitis |
_version_ |
1724542871456972800 |